DAWNA FRANKLIN: Open Payments
NPI 1174587554 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 34 payments from 15 companies in 2025. Trend: 2023 $574 · 2024 $478 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $139 |
| Sumitomo Pharma America, Inc. | 5 | $84 |
| Pacira Pharmaceuticals Incorporated | 3 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $57 |
| SHIELD THERAPEUTICS INC | 2 | $38 |
| Organon LLC | 2 | $37 |
| Kerecis Limited | 1 | $33 |
| Exeltis, USA Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
Products named: Veozah, Exparel, Mirena, GEMTESA, ACCRUFER, NEXPLANON, MYFEMBREE, Kerecis SurgiClose.
Industry payments across AL — which companies pay providers there.
